Original Research
Published on 24 May 2021
Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer
in Cancer Endocrinology
![Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer](https://www.frontiersin.org/files/myhome article library/667798/667798_Thumb_400.jpg)
- 3,151 views
- 11 citations
Original Research
Published on 24 May 2021
in Cancer Endocrinology
Original Research
Published on 20 May 2021
in Cancer Endocrinology
Case Report
Published on 19 May 2021
in Cancer Endocrinology
Case Report
Published on 19 May 2021
in Cancer Endocrinology
Review
Published on 19 May 2021
in Cancer Endocrinology
Case Report
Published on 13 May 2021
in Cancer Endocrinology
Correction
Published on 11 May 2021
in Cancer Endocrinology
Review
Published on 06 May 2021
in Cancer Endocrinology
Review
Published on 03 May 2021
in Cancer Endocrinology
Original Research
Published on 30 Apr 2021
in Cancer Endocrinology
Case Report
Published on 30 Apr 2021
in Cancer Endocrinology
Original Research
Published on 27 Apr 2021
in Cancer Endocrinology
Review
Published on 26 Apr 2021
in Cancer Endocrinology
Original Research
Published on 26 Apr 2021
in Cancer Endocrinology
Perspective
Published on 23 Apr 2021
in Cancer Endocrinology
Original Research
Published on 23 Apr 2021
in Cancer Endocrinology